Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (11-20 of 331) with videos related to

Pageof 34
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Is there a limit to the normality of blood products?L Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Medical practice is actually dictated by lawyersL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
How to limit the overabundance of health care administratorsL Degos
Leukemia|June 1, 1994
Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survivalL Degos
Leukemia & Lymphoma|January 1, 1994
Differentiation therapy of leukemiaL Degos
Leukemia|May 1, 1993
Annual guest lecture, Leukaemia Research Fund (UK): differentiation therapy and leukemiaL Degos
La Revue Du Praticien|March 1, 1980
[Principles of immunogenetics. HLA and diseases]L Degos
Revue De L'Infirmiere|February 1, 1980
[Acute leukemia]L Degos
International Journal of Cell Cloning|March 1, 1992
All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapyL Degos
Pathologie-Biologie|November 1, 1992
[HLA and cancer]L Degos
Pageof 34

Showing results (11-20 of 331) with videos related to

Sort By:
Pageof 34
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Is there a limit to the normality of blood products?L Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Medical practice is actually dictated by lawyersL Degos
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
How to limit the overabundance of health care administratorsL Degos
Leukemia|June 1, 1994
Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survivalL Degos
Leukemia & Lymphoma|January 1, 1994
Differentiation therapy of leukemiaL Degos
Leukemia|May 1, 1993
Annual guest lecture, Leukaemia Research Fund (UK): differentiation therapy and leukemiaL Degos
La Revue Du Praticien|March 1, 1980
[Principles of immunogenetics. HLA and diseases]L Degos
Revue De L'Infirmiere|February 1, 1980
[Acute leukemia]L Degos
International Journal of Cell Cloning|March 1, 1992
All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapyL Degos
Pathologie-Biologie|November 1, 1992
[HLA and cancer]L Degos
Pageof 34